+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Alkermes plc - logo

Alkermes is a leader in innovative medicines that address the needs of people living with debilitating diseases. Alkermes develops products that are designed to make a meaningful difference in the way patients manage their disease. Alkermes produces innovative treatments for major clinical conditions specifically focused on central nervous system (CNS) disorders, such as schizophrenia, depression, addiction and multiple sclerosis.

From
Modified Release Neurology Therapeutics - Product Thumbnail Image

Modified Release Neurology Therapeutics

  • Report
  • January 2024
  • 125 Pages
  • Global
From
From
From
From
Treatment Resistant Depression - Pipeline Insight, 2024 - Product Thumbnail Image

Treatment Resistant Depression - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
Generalized Anxiety Disorder Market Report 2025 - Product Thumbnail Image

Generalized Anxiety Disorder Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Drug Delivery Devices Market Report 2025 - Product Thumbnail Image

Drug Delivery Devices Market Report 2025

  • Report
  • March 2025
  • 250 Pages
  • Global
From
Controlled Release Drug Delivery Market Report 2025 - Product Thumbnail Image

Controlled Release Drug Delivery Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Alcoholic Hepatitis Treatment Market Report 2025 - Product Thumbnail Image

Alcoholic Hepatitis Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Long-Acting Injectable Drugs - Product Thumbnail Image

Long-Acting Injectable Drugs

  • Report
  • December 2021
  • 170 Pages
  • Global
Neurology Market: A Research Overview - Product Thumbnail Image

Neurology Market: A Research Overview

  • Report
  • July 2019
  • 194 Pages
  • Global
From
Loading Indicator